1. Executive Summary 2. Global HIV Drugs Market Size & Analysis (2015 – 2025) 3. Global HIV Drugs Market Share & Y-o-Y Growth (%),2015 – 2025 4. Latest Happenings in Global HIV Drugs Market 5. Key Drivers & Inhibitors of the Global HIV Drugs Market 5.1 Market Drivers 5.2 Inhibitors 6. Global Top 22 HIV Drugs Market Assessment & Opportunity (2015 – 2025) 6.1 Tivicay (dolutegravir) 6.2 Triumeq (dolutegravir/abacavir/lamivudine) 6.3 Juluca (dolutegravir and rilpivirine) 6.4 Epzicom (abacavir and lamivudine) 6.5 Selzentry (maraviroc) 6.6 Kaletra (Iopinavir/ritonavir) 6.7 Sustiva (efavirenz) 6.8 Reyataz (atazanavir) 6.9 Atripla (efavirenz/emtricitabine/tenofovir) 6.10 Truvada (emtricitabine/tenofovir disoproxil fumarate) 6.11 Viread (tenofovir disoproxil fumarate) 6.12 Complera (emtricitabine, rilpivirine, and tenofovir disoproxil fumarate) 6.13 Stribild (elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate) 6.14 Genvoya (elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide) 6.15 Biktarvy (bictegravir, emtricitabine, and tenofovir alafenamide) 6.16 Descovy (emtricitabine and tenofovir alafenamide) 6.17 Odefsey (emtricitabine, rilpivirine, and tenofovir alafenamide) 6.18 Prezista/Prezcobix (darunavir ethanolate /cobicistat) 6.19 Edurant (rilpivirine) 6.20 Isentress (raltegravir) 6.21 Pifeltro (doravirine) 6.22 Delstrigo (doravirine / lamivudine / tenofovir disoproxil fumarate) 7. Partnerships, Collaboration & Licensing Agreement in Global HIV Drugs Market 8. Promising HIV Drugs in Clinical Development 9. HIV Drugs Clinical Trial Insight by Phase, Institute & Country,2018 10. Key Companies Analysis 10.1 AbbVie 10.1.1 Business Overview 10.1.2 Recent Development 10.2 GlaxoSmithKline (GSK) 10.2.1 Business Overview 10.2.2 Recent Development 10.3 Gilead Sciences 10.3.1 Business Overview 10.3.2 Recent Development 10.4 Merck 10.4.1 Business Overview 10.4.2 Recent Development 10.5 Bristol Myers Squibb 10.5.1 Business Overview 10.5.2 Recent Development 10.6 Janssen (Johnson & Johnson) 10.6.1 Business Overview 10.6.2 Recent Development

Table 3–1: Global HIV Drugs Market Share & Y–o–Y Growth (%), 2015 – 2018 Table 3–2: Global HIV Drugs Market Share & Y–o–Y Growth Forecast (%), 2019 – 2025 Table 7–1: Partnerships, Collaboration & Licensing Agreement in Global HIV Drugs MarketFigure 2–1: Global HIV Drugs Market Size (Million US$),2015 – 2018 Figure 2–2: Global HIV Drugs Market Size Forecast (Million US$),2019 – 2025 Figure 6–1: Global Tivicay Market Value (Million US$),2015 – 2018 Figure 6–2: Global Tivicay Market Value Forecast (Million US$),2019 – 2025 Figure 6–3: Global Triumeq Market Value (Million US$),2015 – 2018 Figure 6–4: Global Triumeq Market Value Forecast (Million US$),2019 – 2025 Figure 6–5: Global Juluca Market Value (Million US$),2015 – 2018 Figure 6–6: Global Juluca Market Value Forecast (Million US$),2019 – 2025 Figure 6–7: Global Epzicom Market Value (Million US$),2015 – 2018 Figure 6–8: Global Epzicom Market Value Forecast (Million US$),2019 – 2025 Figure 6–9: Global Selzentry Market Value (Million US$),2015 – 2018 Figure 6–10: Global Selzentry Market Value Forecast (Million US$),2019 – 2025 Figure 6–11: Global Kaletra Market Value (Million US$),2015 – 2018 Figure 6–12: Global Kaletra Market Value Forecast (Million US$),2019 – 2025 Figure 6–13: Global Sustiva Market Value (Million US$),2015 – 2018 Figure 6–14: Global Sustiva Market Value Forecast (Million US$),2019 – 2025 Figure 6–15: Global Reyataz Market Value (Million US$),2015 – 2018 Figure 6–16: Global Reyataz Market Value Forecast (Million US$),2019 – 2025 Figure 6–17: Global Atripla Market Value (Million US$),2015 – 2018 Figure 6–18: Global Atripla Market Value Forecast (Million US$),2019 – 2025 Figure 6–19: Global Truvada Market Value (Million US$),2015 – 2018 Figure 6–20: Global Truvada Market Value Forecast (Million US$),2019 – 2025 Figure 6–21: Global Viread Market Value (Million US$),2015 – 2018 Figure 6–22: Global Viread Market Value Forecast (Million US$),2019 – 2025 Figure 6–23: Global Complera Market Value (Million US$),2015 – 2018 Figure 6–24: Global Complera Market Value Forecast (Million US$),2019 – 2025 Figure 6–25: Global Stribild Market Value (Million US$),2015 – 2018 Figure 6–26: Global Stribild Market Value Forecast (Million US$),2019 – 2025 Figure 6–27: Global Genvoya Market Value (Million US$),2015 – 2018 Figure 6–28: Global Genvoya Market Value Forecast (Million US$),2019 – 2025 Figure 6–29: Global Biktarvy Market Value Forecast (Million US$),2018 – 2025 Figure 6–30: Global Descovy Market Value (Million US$),2015 – 2018 Figure 6–31: Global Descovy Market Value Forecast (Million US$),2019 – 2025 Figure 6–32: Global Odefsey Market Value (Million US$),2015 – 2018 Figure 6–33: Global Odefsey Market Value Forecast (Million US$),2019 – 2025 Figure 6–34: Global Prezcobix Market Value (Million US$),2015 – 2018 Figure 6–35: Global Prezcobix Market Value (Million US$),2019 – 2025 Figure 6–36: Global Edurant Market Value (Million US$),2015 – 2018 Figure 6–37: Global Edurant Market Value Forecast (Million US$),2019 – 2025 Figure 6–38: Global Isentress Market Value (Million US$),2015 – 2018 Figure 6–39: Global Isentress Market Value Forecast (Million US$),2019 – 2025 Figure 6–40: Global Pifeltro Market Value & Forecast (Million US$),2018 – 2025 Figure 6–41: Global Delstrigo Market Value & Forecast (Million US$),2018 – 2025

AbbVie, Merck, Gilead Sciences, Bristol–Myers Squibb, Janssen (Johnson & Johnson), GlaxoSmithKline (GSK)